Aptevo Therapeutics, Inc. (APVO)
9.29
-0.54
(-5.49%)
USD |
NASDAQ |
Jan 21, 16:00
9.28
-0.01
(-0.11%)
After-Hours: 20:00
Aptevo Therapeutics EPS Diluted (Quarterly): -40.13 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 6.211 |
| Dermata Therapeutics, Inc. | -1.648 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.028M |
| Total Expenses (Quarterly) | 9.028M |
| Enterprise Value | 139.47M |
| Earnings Yield | -35.86K% |
| Normalized Earnings Yield | -35857.81 |